Indian Journal of Public Health Research & Development · 2019 · 10 citations · 0 references
MedicineCardiologyClinical SciencesClinical CardiologyImmunopathologyInflammationAcute InflammationCardiac BiomarkersCardiovascular DiseaseCoronary Artery DiseaseInflammatory BiomarkersIschemic Heart DiseaseAcute-phase MediatorsAcute-phase ProteinsAtherosclerosis RiskC-reactive Protein TestingInflammation In Cardiovascular DiseaseInflammatory Cardiac BiomarkersPlaque InflammationRisk Marker Identification
Atherosclerosis is multi-factorial process, which involves the accumulation of lipid, macrophages and intimal plaques in smooth muscle cell of both large and medium sized arteries. Considerable scientific studies have publicized that inflammation plays a major role in the initiation, progression and destabilization of atheroma. C-reactive protein (CRP) is a non-specific acute phase protein produced by liver in response to injury, infection and inflammation (1). C-reactive protein is an inflammatory marker can be considered as global risk assessment for coronary heart disease (2). The objective of study is to determine the CRP level as risk marker in acute myocardial infarction patients.